Dupilumab-induced peripheral neuropathy in a patient with severe asthma

Ann Allergy Asthma Immunol. 2022 May;128(5):611. doi: 10.1016/j.anai.2022.01.028.

Authors

Mayuka Yamane¹, Hiroshi Ohnishi², Kimiko Tsuji¹, Kazuki Anabuki¹, Akihito Yokoyama¹

Affiliations

¹ Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan.
² Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan. Electronic address: honi@kochi-u.ac.jp.

PMID: 35489800
DOI: 10.1016/j.anai.2022.01.028

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Asthma* / drug therapy
Humans
Peripheral Nervous System Diseases* / chemically induced

Substances

Antibodies, Monoclonal, Humanized
dupilumab